Telemetry Investments’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$56K Sell
470,000
-30,000
-6% -$4.33K 0.09% 98
2022
Q3
$90K Buy
500,000
+427,000
+585% +$230K 0.12% 120
2022
Q2
$129K Buy
73,000
+6,500
+10% +$14.6K 0.15% 117
2022
Q1
$200K Sell
66,500
-32,000
-32% -$85.6K 0.32% 93
2021
Q4
$366K Buy
98,500
+47,500
+93% +$278K 0.47% 73
2021
Q3
$302K Buy
51,000
+499
+1% +$7.01K 0.41% 79
2021
Q2
$878K Sell
50,501
-23,966
-32% -$437K 1.21% 27
2021
Q1
$1.42M Buy
74,467
+26,978
+57% +$492K 1.61% 17
2020
Q4
$831K Sell
47,489
-94,187
-66% -$1.13M 1.4% 24
2020
Q3
$1.51M Buy
+141,676
New +$1.45M 3.27% 5

Other funds holding HGEN

Telemetry Investments's HGEN Position: Q4 2022 in Review

Telemetry Investments reduced its HUMANIGEN, INC. (HGEN) stake by 6% in Q4 2022, selling an estimated $4.33K and leaving 470,000 shares worth $56K. The position accounts for 0.09% of the portfolio, ranked #98.

Telemetry Investments first reported a position in HGEN in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.51M in Q3 2020. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

  • Telemetry Investments held 470,000 shares of HUMANIGEN, INC. worth $56K as of Q4 2022.
  • Telemetry Investments sold 30,000 HUMANIGEN, INC. shares in Q4 2022, an estimated $4.33K.
  • HUMANIGEN, INC. made up 0.09% of Telemetry Investments's portfolio in Q4 2022, its #98 holding.
  • Telemetry Investments first reported a position in HUMANIGEN, INC. in Q3 2020 and has held it in 10 quarters since.
  • Telemetry Investments's HUMANIGEN, INC. position peaked at $1.51M in Q3 2020.
  • 48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.